User:Syed Hassan Abbas Kazmi

Syed Hassan Kazmi, MD

Contact:

Email: skazmi@bidmc.harvard.edu

Syed Hassan Kazmi, MD (also published as Syed Hassan Abbas Kazmi, Syed H. A. Kazmi, and Hassan A. Kazmi) is a physician and clinical researcher with peer-reviewed publications in cardiovascular medicine, thrombosis, interventional cardiology, outcomes research, preventive cardiology, PCI, Electrophysiology, AI, and evidence synthesis.

External links

• ORCID: 0009-0007-4698-6871
• Wikidata: Q138033993
• Google Scholar: Profile
• NPI listing: 1508494584
• LinkedIn: hassan-kazmimd
• ResearchGate: Syed-Hassan-Kazmi

Research focus

• Cardiovascular outcomes and evidence synthesis (meta-analysis, trial design, protocol development, medical education, agentic AI, imaging assistant, explainable AI or XAI)
• Antithrombotic therapy and venous thromboembolism (VTE)
• Post–myocardial infarction risk biology and HDL/ApoA-I therapeutics
• Cardiovascular devices and ischemia detection systems

Selected peer-reviewed manuscripts

1. The AngelMed Guardian® System in the Detection of Coronary Artery Occlusion: Current Perspectives. Med Devices (Auckl). 2020;13:1–12. doi:10.2147/MDER.S219865. PMID:32021496. PMCID:PMC6954830.
2. CSL112 (Apolipoprotein A-I [Human)Strongly Enhances Plasma Apoa-I and Cholesterol Efflux Capacity in Post-Acute Myocardial Infarction Patients: A PK/PD Substudy of the AEGIS-I Trial.] J Cardiovasc Pharmacol Ther. 2022 Jan-Dec;27:10742484221121507. doi: 10.1177/10742484221121507. PMID: 36282079.
3. Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis. Front Cardiovasc Med. 2021 Dec 13;8:774418. doi: 10.3389/fcvm.2021.774418. PMID: 34966797; PMCID: PMC8710716.
4. Effect of azithromycin and hydroxychloroquine in patients hospitalized with COVID-19: Network meta-analysis of randomized controlled trials. J Med Virol. 2021. PMID:34370328. PMCID:PMC8427058.
5. ApoA-I infusion therapies following acute coronary syndrome: Past, present, and future. Curr Atheroscler Rep. 2022;24:585–597. doi:10.1007/s11883-022-01025-7. PMID:35524914. PMCID:PMC9236992.
6. Early and late recurrent cardiovascular events among high-risk patients with an acute coronary syndrome: Meta-analysis of phase III studies and implications on trial design. Clin Cardiol. 2022;45(3):299–307. doi:10.1002/clc.23773. PMID:35019162. PMCID:PMC8922536.
7. Biological basis and proposed mechanism of action of CSL112 (apolipoprotein A-I [human) for prevention of major adverse cardiovascular events in patients with myocardial infarction.] Eur Heart J Cardiovasc Pharmacother. 2023;9(4):387–398. PMID:36787889. PMCID:PMC10236524.
8. Cholesterol Efflux Capacity and Measurement Assays: A Novel Biomarker of High-Density Lipoprotein (HDL) Function.
9. Association of anemia with venous thromboembolism in acutely ill hospitalized patients: an APEX trial substudy. Am J Med. 2018;131(8):972.e1–972.e7. PMID:29660351.
10. Reduction of cardiovascular mortality and ischemic events in acute medically ill patients: an APEX substudy. Circulation. 2019;139(9):1234–1236. PMID:30802169.
11. Most promising therapies in interventional cardiology. Curr Cardiol Rep. 2019. PMID:30868280.
12. The Landscape of Pharmacological Interventional Trials for the Treatment or Prevention of Coronary Artery Disease: Analysis of clinicaltrials.gov Listings From 2008 to 2022. Circulation. 2023;148(Suppl_1):A14710-A.
13. Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolism. Expert Rev Cardiovasc Ther. 2018 Nov;16(11):845-855. doi: 10.1080/14779072.2018.1534068. Epub 2018 Oct 15. PMID: 30296387.

Conference abstracts / presentations

• Hypoalbuminemia and Its Association with Venous Thromboembolism in Acutely Ill Hospitalized Patients: Findings From the APEX Trial. Circulation (Suppl). 2018. DOI: Not listed. PMID: Not listed. PMCID: Not listed.
• Prognostic Value of C-Reactive Protein as Inflammatory Marker for Venous Thromboembolism in Acutely Ill Hospitalized Patients: Analysis from the APEX Trial. Circulation (Suppl). 2018. DOI: Not listed. PMID: Not listed. PMCID: Not listed.
• Paradoxical protective effect of obesity on the risk of venous thromboembolism: observations from APEX trial. JACC (Suppl). 2019. DOI: 10.1016/S0735-1097(19)32550-1. PMID: Not listed. PMCID: Not listed.
• COMPARATIVE EFFICACY AND SAFETY OF DIRECT ORAL ANTICOAGULANTS AND WARFARIN AMONG FRAIL ELDERLY PATIENTS WITH ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS. JACC (Poster Contributions). 2024. DOI: 10.1016/S0735-1097(24)02090-4. PMID: Not listed. PMCID: Not listed.
• UPDATED META-ANALYSIS OF RANDOMIZED TRIALS COMPARING COMPLETE VERSUS CULPRIT-ONLY REVASCULARIZATION IN PATIENTS WITH MYOCARDIAL INFARCTION AND MULTIVESSEL CORONARY DISEASE. JACC (Suppl). 2025. DOI: 10.1016/S0735-1097(25)02434-9. PMID: Not listed. PMCID: Not listed.

Education & training

• Medical education: King Edward Medical University
• Graduate medical training: Internal Medicine Residency (Mass General Brigham)
• Subspecialty training: Cardiovascular Disease Fellowship (Reading Hospital / Tower Health)

Name variants

• Syed Hassan Kazmi
• Syed Hassan Abbas Kazmi
• Syed H A Kazmi
• Hassan A Kazmi
• Hassan Kazmi
• SH Kazmi
• SHA Kazmi

Authored Pages

Textbook_of_clinical_trials Venous Thromboembolism Adult-onset Still’s disease Diabetic ketoacidosis (DKA) Psoriasis Alzheimer's disease Celiac disease Toxic shock syndrome Mucormycosis Dermatophytosis Whipworm infection

Bourbon virus infection Sleep deprivation survey Conn's Syndrome Gastroesophageal varices Glomerulonephritis Nephrolithiasis Hematuria

Down's Syndrome Urinary Incontinence Pathophysiology of Atrial Fibrillation Pathophysiology and molecular mechanisms of acute myeloid leukemia 2018 AHA/ASA guidelines for management of acute ischemic stroke Mechanical Ventilation Resident Survival Guide Deep vein thrombosis medical therapy Drug page for Andexxa (Reversal agent for Factor Xa inhibitors- approved by FDA in May 2018)

Corevalve Evolut R (Medtronic) and Edwards Sapien 3 (Edward Lifesciences) Valves Reveal Equivalence in Transcatheter Aortic Valve Implantation (TAVI) in a Head-to-Head Comparison Polymer coated sustained-release Eluvia DES outshines non-polymer coated Zilver DES for femoropopliteal artery stenosis Dual Therapy Reduces Bleeding Compared with Triple Therapy in A-Fib after PCI ‘Lowest is best’ when it comes to blood LDL cholesterol levels (A meta-analysis shows lower blood LDL cholesterol levels may be efficacious and safe)

Deciphering the Underpinnings of MINOCA (MI with Non-Obstructive Coronary Arteries) Novel Target For STEMI Patients: Cholesterol Efflux Capacity Inversely Associated with All-Cause Mortality

Reviewed Pages

Cryptococcus infection Fibromyalgia Trypanosomiasis Chickenpox Lupus Bronchiolitis Pheochromocytoma Prolactinoma Pituitary apoplexy SIADH

Protein-energy malnutrition Thyroid nodule Hyperosmolar hyperglycemic syndrome Autoimmune polyendocrine syndrome Hirsutism Hypocalciuric hypercalcemia Hypoparathyroidism Hypopituitarism Gastroparesis Budd Chiari syndrome

Zenker diverticulum Stomach cancer Irritable bowel syndrome Short bowel syndrome Dumping syndrome Cholangitis Cirrhosis Intusussception TIPS Hepatocellular carcinoma

Dyspepsia Ileus Acute diarrhea Femoral hernia Oral cancer Small cell lung cancer Pneumonia Adenocarcinoma Respiratory failure Rabies

Languages

English: Fluent in reading, writing and speaking

Urdu: Fluent in reading, writing and speaking

Hindi: Fluent in speaking

Punjabi: Fluent in reading, writing and speaking

Arabic: Fluent in reading and writing

Persian: Fluent in reading and writing